Associations of soybean products intake with blood pressure changes and hypertension incidence: the China-PAR project.

Blood pressure changes Chinese population Cohort study Hypertension Soybean products

Journal

Journal of geriatric cardiology : JGC
ISSN: 1671-5411
Titre abrégé: J Geriatr Cardiol
Pays: China
ID NLM: 101237881

Informations de publication

Date de publication:
28 Jul 2020
Historique:
entrez: 1 9 2020
pubmed: 31 8 2020
medline: 31 8 2020
Statut: ppublish

Résumé

The relationships between dietary intake of soybean products and incident hypertension were still uncertain. This study aimed to illustrate the associations between intake of soybean products with risks of incident hypertension and longitudinal changes of blood pressure in a prospective cohort study. We included 67, 499 general Chinese adults from the Project of Prediction for Atherosclerosis Cardiovascular Disease Risk in China (China-PAR). Information about soybean products consumption was collected by standardized questionnaires, and study participants were categorized into the ideal (≥ 125 g/day) or non-ideal (< 125 g/day) group. Hazard ratios (HRs) and corresponding 95% confidence intervals (95% CIs) for incident hypertension were calculated using Cox proportional hazard models. Among participants with repeated measures of blood pressure, generalized linear models were used to examine the relationships between soybean products consumption and blood pressure changes. During a median follow-up of 7.4 years, compared with participants who consumed < 125 g of soybean products per day, multivariable adjusted HR for those in the ideal group was 0.73 (0.67-0.80). This inverse association remained robust across most subgroups while significant interactions were tested between soybean products intake and age, sex, urbanization and geographic region ( Our study showed that intake of soybean products might reduce the long-term blood pressure levels and hypertension incidence among Chinese population, which has important public health implications for primary prevention of hypertension.

Sections du résumé

BACKGROUND BACKGROUND
The relationships between dietary intake of soybean products and incident hypertension were still uncertain. This study aimed to illustrate the associations between intake of soybean products with risks of incident hypertension and longitudinal changes of blood pressure in a prospective cohort study.
METHODS METHODS
We included 67, 499 general Chinese adults from the Project of Prediction for Atherosclerosis Cardiovascular Disease Risk in China (China-PAR). Information about soybean products consumption was collected by standardized questionnaires, and study participants were categorized into the ideal (≥ 125 g/day) or non-ideal (< 125 g/day) group. Hazard ratios (HRs) and corresponding 95% confidence intervals (95% CIs) for incident hypertension were calculated using Cox proportional hazard models. Among participants with repeated measures of blood pressure, generalized linear models were used to examine the relationships between soybean products consumption and blood pressure changes.
RESULTS RESULTS
During a median follow-up of 7.4 years, compared with participants who consumed < 125 g of soybean products per day, multivariable adjusted HR for those in the ideal group was 0.73 (0.67-0.80). This inverse association remained robust across most subgroups while significant interactions were tested between soybean products intake and age, sex, urbanization and geographic region (
CONCLUSIONS CONCLUSIONS
Our study showed that intake of soybean products might reduce the long-term blood pressure levels and hypertension incidence among Chinese population, which has important public health implications for primary prevention of hypertension.

Identifiants

DOI: 10.11909/j.issn.1671-5411.2020.07.005 PMID: 32863820 PMC: PMC7416064
pubmed: 32863820
doi: 10.11909/j.issn.1671-5411.2020.07.005
pii: jgc-17-7-384
pmc: PMC7416064
doi:

Types de publication

Journal Article

Langues

eng

Pagination

384-392

Informations de copyright

Copyright and License information: Journal of Geriatric Cardiology 2020.

Références

Nutrients. 2017 Mar 24;9(4):
pubmed: 28338639
Nutr Rev. 2011 Aug;69(8):432-48
pubmed: 21790611
Circulation. 2018 May 29;137(22):2344-2356
pubmed: 29449338
Br J Nutr. 2011 Aug;106(3):317-26
pubmed: 21342608
J Nutr. 2017 Sep;147(9):1749-1756
pubmed: 28724661
Circulation. 2016 Nov 8;134(19):1430-1440
pubmed: 27682885
Am J Clin Nutr. 2015 May;101(5):966-82
pubmed: 25809855
JAMA. 2003 May 21;289(19):2560-72
pubmed: 12748199
Circulation. 1993 Nov;88(5 Pt 1):2460-70
pubmed: 8222141
Am J Clin Nutr. 2008 Jul;88(1):38-50
pubmed: 18614722
Nutr Metab Cardiovasc Dis. 2012 Jun;22(6):463-70
pubmed: 21310599
Arch Intern Med. 2007 May 28;167(10):1060-7
pubmed: 17533209
J Agric Food Chem. 2014 Aug 20;62(33):8247-55
pubmed: 25074337
Hypertension. 1991 Jan;17(1 Suppl):I16-20
pubmed: 1986996
J Diet Suppl. 2020;17(3):286-299
pubmed: 30955400
J Am Coll Nutr. 2004 Feb;23(1):85-91
pubmed: 14963058
J Nutr. 2002 Feb;132(2):276-82
pubmed: 11823590
Nutrients. 2016 Nov 24;8(12):
pubmed: 27886135
J Nutr. 2001 Apr;131(4):1202-6
pubmed: 11285326
J Hypertens. 2013 Feb;31(2):384-92
pubmed: 23203140
J Nutr. 2008 Dec;138(12):2413-21
pubmed: 19022966
Prev Med. 2003 Jun;36(6):692-7
pubmed: 12744912
Lancet. 2005 Jan 15-21;365(9455):217-23
pubmed: 15652604
Hum Reprod Update. 2009 Jul-Aug;15(4):423-40
pubmed: 19299447
Public Health Nutr. 2002 Dec;5(6B):1217-26
pubmed: 12639228
Menopause. 2017 Dec;24(12):1338-1350
pubmed: 29189602
J Nutr. 2002 Jul;132(7):1900-2
pubmed: 12097666
Ann Intern Med. 2005 Jul 5;143(1):1-9
pubmed: 15998749
J Hypertens. 2010 Oct;28(10):1971-82
pubmed: 20577121
Asia Pac J Clin Nutr. 2004;13(2):204-9
pubmed: 15228989
Sci China Life Sci. 2018 May;61(5):504-514
pubmed: 29721777
Am J Clin Nutr. 2005 May;81(5):1012-7
pubmed: 15883423
Eur Rev Med Pharmacol Sci. 2014;18(14):2070-5
pubmed: 25027349
J Clin Endocrinol Metab. 2001 Jul;86(7):3053-60
pubmed: 11443167
J Zhejiang Univ Sci B. 2016 Sep;17(9):649-56
pubmed: 27604857

Auteurs

Jia-Liu Wei (JL)

Key Laboratory of Cardiovascular Epidemiology, Chinese Academy of Medical Sciences, Beijing, China.
Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Xin-Yan Wang (XY)

Key Laboratory of Cardiovascular Epidemiology, Chinese Academy of Medical Sciences, Beijing, China.
Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Fang-Chao Liu (FC)

Key Laboratory of Cardiovascular Epidemiology, Chinese Academy of Medical Sciences, Beijing, China.
Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Ji-Chun Chen (JC)

Key Laboratory of Cardiovascular Epidemiology, Chinese Academy of Medical Sciences, Beijing, China.
Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Jie Cao (J)

Key Laboratory of Cardiovascular Epidemiology, Chinese Academy of Medical Sciences, Beijing, China.
Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Jian-Xin Li (JX)

Key Laboratory of Cardiovascular Epidemiology, Chinese Academy of Medical Sciences, Beijing, China.
Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Dong-Sheng Hu (DS)

Department of Prevention Medicine, Shenzhen University School of Medicine, Shenzhen, China.
Department of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, China.

Chong Shen (C)

Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing, China.

Fang-Hong Lu (FH)

Cardio-Cerebrovascular Control and Research Center, Institute of Basic Medicine, Shandong First Medical University, Jinan, Shandong, China.

Ying-Xin Zhao (YX)

Cardio-Cerebrovascular Control and Research Center, Institute of Basic Medicine, Shandong First Medical University, Jinan, Shandong, China.

Jian-Feng Huang (JF)

Key Laboratory of Cardiovascular Epidemiology, Chinese Academy of Medical Sciences, Beijing, China.
Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Xiang-Feng Lu (XF)

Key Laboratory of Cardiovascular Epidemiology, Chinese Academy of Medical Sciences, Beijing, China.
Department of Epidemiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Classifications MeSH